Cargando…

Comparative Efficacy of AZD9496 and Fulvestrant on the Growth of Pituitary Adenoma via Blocking JAK2/STAT5B Pathway

Total 158 gonadotropin-type pituitary adenoma tissue specimens were collected and the expression of ESR1 in gonadotropin-type pituitary adenoma and its association with the overall survival of patients were analyzed. Transcriptome-sequencing data containing 79 cases of gonadotropin-type pituitary ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qian, Shen, Yutao, Xiong, Yujia, Bai, Jiwei, Zhang, Yazhuo, Li, Chuzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809331/ https://www.ncbi.nlm.nih.gov/pubmed/36605480 http://dx.doi.org/10.7150/jca.79726

Ejemplares similares

The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance
por: Nardone, Agostina, et al.
Publicado: (2018)

Effects of fulvestrant on biological activity and Wnt expression in rat GH3 cells☆
por: Bai, Jiwei, et al.
Publicado: (2012)

The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma
por: Zhu, Haibo, et al.
Publicado: (2019)

Identification of Differentially Expressed Genes in Pituitary Adenomas by Integrating Analysis of Microarray Data
por: Zhao, Peng, et al.
Publicado: (2015)

Corrigendum to “Identification of Differentially Expressed Genes in Pituitary Adenomas by Integrating Analysis of Microarray Data”
por: Zhao, Peng, et al.
Publicado: (2018)

Analysis of Ki67, HMGA1, MDM2, and RB expression in nonfunctioning pituitary adenomas
por: Yao, Xiaohui, et al.
Publicado: (2017)

Germline mutations in MEN1 are associated with the tumorigenesis of pituitary adenoma associated with meningioma
por: Zhu, Haibo, et al.
Publicado: (2020)

Proteomics Analysis Identified ASNS as a Novel Biomarker for Predicting Recurrence of Skull Base Chordoma
por: Shen, Yutao, et al.
Publicado: (2021)

Loss of SMARCB1 promotes autophagy and facilitates tumour progression in chordoma by transcriptionally activating ATG5
por: Li, Mingxuan, et al.
Publicado: (2021)

High Red Cell Distribution Width Independently Predicts Adverse Survival in Patients with Newly Diagnosed Skull Base Chordoma
por: Li, Mingxuan, et al.
Publicado: (2021)

High systemic inflammation score is associated with adverse survival in skull base chordoma
por: Li, Mingxuan, et al.
Publicado: (2022)

A two-circRNA signature predicts tumour recurrence in clinical non-functioning pituitary adenoma
por: Guo, Jing, et al.
Publicado: (2019)

Smad3 and phospho-Smad3 are potential markers of invasive nonfunctioning pituitary adenomas
por: Liu, Chunhui, et al.
Publicado: (2016)

Screening and Identification of Key Microenvironment-Related Genes in Non-functioning Pituitary Adenoma
por: Guo, Jing, et al.
Publicado: (2021)

Research advances on the immune research and prospect of immunotherapy in pituitary adenomas
por: Nie, Ding, et al.
Publicado: (2021)

Analysis of the Prognostic and Immunological Role of HSPB1 in Pituitary Adenoma: A Potential Target for Therapy
por: Zhao, Sida, et al.
Publicado: (2023)

Alterations of regional homogeneity and functional connectivity in pituitary adenoma patients with visual impairment
por: Song, Guidong, et al.
Publicado: (2017)

Endoscopic Endonasal Surgical Strategy for Skull Base Chordomas Based on Tumor Growth Directions: Surgical Outcomes of 167 Patients During 3 Years
por: Bai, Jiwei, et al.
Publicado: (2021)

Identifying critical protein-coding genes and long non-coding RNAs in non-functioning pituitary adenoma recurrence
por: Guo, Jing, et al.
Publicado: (2021)

Whole-exome sequencing identifies variants in invasive pituitary adenomas
por: Lan, Xiaolei, et al.
Publicado: (2016)

CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial–mesenchymal transition
por: Li, Bin, et al.
Publicado: (2019)

A Novel Three-LncRNA Signature Predicting Tumor Recurrence in Nonfunctioning Pituitary Adenomas
por: Cheng, Sen, et al.
Publicado: (2021)

Predicting the regrowth of clinically non-functioning pituitary adenoma with a statistical model
por: Cheng, Sen, et al.
Publicado: (2019)

PALB2 as a factor to predict the prognosis of patients with skull base chordoma
por: Xiong, Yujia, et al.
Publicado: (2022)

High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma
por: Xiong, Yujia, et al.
Publicado: (2021)

Overexpression of the Notch3 receptor and its ligand Jagged1 in human clinically non-functioning pituitary adenomas
por: LU, RUNCHUN, et al.
Publicado: (2013)

Integration of Proteomics and Metabolomics Revealed Metabolite–Protein Networks in ACTH-Secreting Pituitary Adenoma
por: Feng, Jie, et al.
Publicado: (2018)

Phosphorylation of kinase insert domain receptor by cyclin-dependent kinase 5 at serine 229 is associated with invasive behavior and poor prognosis in prolactin pituitary adenomas
por: Xie, Weiyan, et al.
Publicado: (2016)

Identification of key genes in invasive clinically non-functioning pituitary adenoma by integrating analysis of DNA methylation and mRNA expression profiles
por: Cheng, Sen, et al.
Publicado: (2019)

Coulomb excitation of $^{94,96}$Kr beam: Deformation in the neutron-rich krypton isotopes
por: Mücher, D, et al.
Publicado: (2009)

In Vivo Characterization of Cortical and White Matter Microstructural Pathology in Growth Hormone-Secreting Pituitary Adenoma
por: Yuan, Taoyang, et al.
Publicado: (2021)

Long non-coding RNA C5orf66-AS1 is downregulated in pituitary null cell adenomas and is associated with their invasiveness
por: Yu, Guoqiang, et al.
Publicado: (2017)

Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes involved in the regrowth of clinically non-functioning pituitary adenoma
por: Cheng, Sen, et al.
Publicado: (2020)

T5224, RSPO2 and AZD5363 are novel drugs against functional pituitary adenoma
por: Zhong, Sheng, et al.
Publicado: (2019)

Use of micro-positron emission tomography with (18)F-fallypride to measure the levels of dopamine receptor-D2 and (18)F-FDG as molecular imaging tracer in the pituitary glands and prolactinomas of Fischer-344 rats
por: Li, Ping, et al.
Publicado: (2016)

Risk factors and management associated with postoperative cerebrospinal fluid leak after endoscopic endonasal surgery for pituitary adenoma
por: Li, Bin, et al.
Publicado: (2022)

LncRNA PCAT6 regulates the progression of pituitary adenomas by regulating the miR-139-3p/BRD4 axis
por: Zhao, Peng, et al.
Publicado: (2021)

Immunohistochemical Study of NR2C2, BTG2, TBX19, and CDK2 Expression in 31 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas
por: Yao, Xiaohui, et al.
Publicado: (2019)

Metabolic profiling reveals distinct metabolic alterations in different subtypes of pituitary adenomas and confers therapeutic targets
por: Feng, Jie, et al.
Publicado: (2019)

The expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas
por: Zhenye, Li, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0g3th0a05impkpuj2e7thoe752